Additionally, emerging evidence suggests that p62 influences genomic stability, microsatellite instability (MSI), tumor mutational burden (TMB), and stem-like programs [60, 67, 98], which are critical hallmarks of tumor immunity and therapeutic responses [20, 42]. Here, SQSTM1 is linked to neoplasm.